Palatin Technologies Inc (PTN)
0.9385
+0.02
(+2.66%)
USD |
NYAM |
Nov 21, 16:00
0.91
-0.03
(-3.04%)
After-Hours: 20:00
Palatin Technologies Enterprise Value: 15.49M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 15.49M |
| November 19, 2024 | 15.80M |
| November 18, 2024 | 16.19M |
| November 15, 2024 | 15.88M |
| November 14, 2024 | 18.53M |
| November 13, 2024 | 20.88M |
| November 12, 2024 | 21.07M |
| November 11, 2024 | 21.07M |
| November 08, 2024 | 23.03M |
| November 07, 2024 | 20.29M |
| November 06, 2024 | 18.92M |
| November 05, 2024 | 20.49M |
| November 04, 2024 | 20.88M |
| November 01, 2024 | 21.07M |
| October 31, 2024 | 21.86M |
| October 30, 2024 | 22.25M |
| October 29, 2024 | 20.10M |
| October 28, 2024 | 21.27M |
| October 25, 2024 | 18.92M |
| October 24, 2024 | 19.12M |
| October 23, 2024 | 18.92M |
| October 22, 2024 | 18.14M |
| October 21, 2024 | 17.36M |
| October 18, 2024 | 16.77M |
| October 17, 2024 | 17.16M |
| Date | Value |
|---|---|
| October 16, 2024 | 15.99M |
| October 15, 2024 | 14.70M |
| October 14, 2024 | 14.56M |
| October 11, 2024 | 14.82M |
| October 10, 2024 | 14.82M |
| October 09, 2024 | 14.88M |
| October 08, 2024 | 14.64M |
| October 07, 2024 | 15.40M |
| October 04, 2024 | 14.88M |
| October 03, 2024 | 13.80M |
| October 02, 2024 | 13.65M |
| October 01, 2024 | 14.82M |
| September 30, 2024 | 15.10M |
| September 27, 2024 | 6.905M |
| September 26, 2024 | 8.824M |
| September 25, 2024 | 9.083M |
| September 24, 2024 | 10.23M |
| September 23, 2024 | 13.91M |
| September 20, 2024 | 15.27M |
| September 19, 2024 | 15.46M |
| September 18, 2024 | 16.82M |
| September 17, 2024 | 17.01M |
| September 16, 2024 | 17.40M |
| September 13, 2024 | 19.14M |
| September 12, 2024 | 19.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.910M
Minimum
Mar 18 2020
215.39M
Maximum
Feb 10 2021
37.74M
Average
29.23M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.745M |
| iBio Inc | 9.932M |
| Theriva Biologics Inc | -12.74M |
| Oragenics Inc | 2.485M |
| Nanoviricides Inc | 15.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.824M |
| Total Expenses (Quarterly) | 7.765M |
| EPS Diluted (Quarterly) | -0.39 |
| Earnings Yield | -216.5% |
| Normalized Earnings Yield | -231.06 |